Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Total Liabilities: 2024-2025

Historic Total Liabilities for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $36.8 million.

  • Pyxis Oncology's Total Liabilities fell 11.54% to $36.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.8 million, marking a year-over-year decrease of 11.54%. This contributed to the annual value of $36.4 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Pyxis Oncology reported Total Liabilities of $36.8 million as of Q3 2025, which was up 3.52% from $35.6 million recorded in Q2 2025.
  • Pyxis Oncology's Total Liabilities' 5-year high stood at $41.6 million during Q3 2024, with a 5-year trough of $32.8 million in Q1 2025.
  • Its 2-year average for Total Liabilities is $36.8 million, with a median of $36.4 million in 2024.
  • Data for Pyxis Oncology's Total Liabilities shows a maximum YoY decreased of 11.54% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Total Liabilities stood at $36.4 million in 2024, then declined by 11.54% to $36.8 million in 2025.
  • Its Total Liabilities was $36.8 million in Q3 2025, compared to $35.6 million in Q2 2025 and $32.8 million in Q1 2025.